PARP inhibitor era in ovarian cancer treatment: a systematic review and meta-analysis of randomized controlled trials

• প্রধান লেখক: István Baradács (লেখক), Brigitta Teutsch (লেখক), Alex Váradi (লেখক), Alexandra Bilá (লেখক), Ádám Vincze (লেখক), Péter Hegyi (লেখক), Tamás Fazekas (লেখক), Balázs Komoróczy (লেখক), Péter Nyirády (লেখক), Nándor Ács (লেখক), Ferenc Bánhidy (লেখক), Balázs Lintner (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: BMC, 2024-02-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract Background Ovarian cancer is the eighth leading cause of cancer-related death among women, characterized by late diagnosis and a high relapse rate. In randomized controlled trials, we aimed to evaluate the efficacy and safety of PARP inhibitors (PARPi) in treating advanced ovarian cancer. M...